Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Unicycive Therapeutics Inc has a consensus price target of $5.25 based on the ratings of 6 analysts. The high is $9 issued by Piper Sandler on April 4, 2024. The low is $2.5 issued by HC Wainwright & Co. on September 3, 2024. The 3 most-recent analyst ratings were released by Benchmark, HC Wainwright & Co., and HC Wainwright & Co. on September 6, 2024, September 3, 2024, and August 15, 2024, respectively. With an average price target of $2.67 between Benchmark, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 592.64% upside for Unicycive Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Unicycive Therapeutics (NASDAQ:UNCY) was reported by Benchmark on September 6, 2024. The analyst firm set a price target for $3.00 expecting UNCY to rise to within 12 months (a possible 669.82% upside). 18 analyst firms have reported ratings in the last year.
The latest analyst rating for Unicycive Therapeutics (NASDAQ:UNCY) was provided by Benchmark, and Unicycive Therapeutics reiterated their speculative buy rating.
There is no last upgrade for Unicycive Therapeutics
There is no last downgrade for Unicycive Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Unicycive Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Unicycive Therapeutics was filed on September 6, 2024 so you should expect the next rating to be made available sometime around September 6, 2025.
While ratings are subjective and will change, the latest Unicycive Therapeutics (UNCY) rating was a reiterated with a price target of $3.00 to $3.00. The current price Unicycive Therapeutics (UNCY) is trading at is $0.39, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.